Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis and SciNeuro BBB “brain-shuttle” Alzheimer’s deal

Lucid Diligence Brief: Novartis and SciNeuro BBB “brain-shuttle” Alzheimer’s…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AirNexis Therapeutics $200 million Series A for PDE3/4 in COPD

Lucid Diligence Brief: AirNexis Therapeutics $200 million Series A for PDE3/4…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Gilead licenses Assembly Bio’s HSV helicase-primase programs

Lucid Diligence Brief: Gilead licenses Assembly Bio’s HSV helicase-primase…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Jacobio and AstraZeneca pan-KRAS asset deal

Lucid Diligence Brief: Jacobio and AstraZeneca pan-KRAS asset deal Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal

Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Vaximm VXM01 License Term Sheet with BCM Europe

Lucid Diligence Brief: Vaximm VXM01 License Term Sheet with BCM Europe…


Privacy Preference Center